课题基金 / 基金详情

Inclusion and participation of older adults from underrepresented populations in cognitive aging and Alzheimer's disease-related research

Inclusion and participation of older adults from underrepresented populations in cognitive aging and Alzheimer's disease-related research
将代表性不足的老年人纳入认知衰老和阿尔茨海默病相关研究
批准号:
10529942
负责人:
Miriam Ashford
金额:
$0.25万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-30 至 2024-09-29

项目摘要

项目成果

Miriam Ashford的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT (parent award) Alzheimer’s disease (AD) is a major public health burden and disproportionately affects underrepresented populations (URPs), including underrepresented ethnoracial groups and those with low socioeconomic status. URPs are chronically underrepresented in AD clinical research, which has substantial scientific and ethical ramifications. The separate and interacting contributions of sociodemographic and other factors to multiple levels of research participation, including enrollment, retention, and study task completion, are not well understood. Based on current health disparities theoretical frameworks, like the biopsychosociocultural model, multiple factors need to be considered. Therefore, the overall scientific objective of this proposal is to investigate multiple biopsychosocial factors affecting inclusion and participation of URPs in different research settings with a specific focus on ethnoracial and low educational attainment URPs. An innovative approach will be used to examine these important hypotheses by leveraging three existing cohorts from different research settings: (1) the Brain Health Registry (BHR), a cognitive aging-related longitudinal research registry, N>70,000, (2) the Alzheimer’s Disease Initiative (ADNI), an in-clinic observational AD study, N>2,000, and (3) the Health and Retirement Study (HRS), a population-based aging study, N>20,000. The two main hypotheses are (1) Associations between URP status and research participation are affected by multiple biopsychosociocultural factors. We will examine the moderating role of biopsychosociocultural factors on URP research participation in BHR and ADNI; (2) Eligibility criteria of AD trials contribute to underrepresentation of URPs. We will apply a list of current AD trial eligibility criteria to the population-based HRS sample to determine and statistically compare sociodemographic characteristics of eligible/ineligible participants. We will further explore the contributions of trial design characteristics on eligibility. This project is both highly novel and significant as it will be the first to conduct an in-depth examination of multiple biopsychosociocultural factors affecting URP inclusion and participation in a variety of different settings. Improved understanding of the role of biosychosociocultural factors on URP research participation is critical to elucidate sources of research participation disparities frequently affecting URPs. Thus, results are likely to have important public health implications, as this study may inform targeted research inclusion and engagement strategies to improve diversity. This research plan is complemented by a training plan that builds on the candidate’s recent transition from clinical research psychology to the aging and AD field, and therefore includes training in (1) cognitive aging/AD and related clinical trials; (2) complex data sets analysis, advanced biostatistics; (3) AD disparities; (4) URP research participation disparities; (5) professional development. The combined research and training plans will prepare the candidate for a successful independent research career focused on increasing diversity in cognitive aging and AD research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inclusion and participation of older adults from underrepresented populations in cognitive aging and Alzheimer's disease-related research
Inclusion and participation of older adults from underrepresented populations in cognitive aging and Alzheimer's disease-related research
Inclusion and participation of older adults from underrepresented populations in cognitive aging and Alzheimer's disease-related research
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: